These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9731583)

  • 1. Hyponatremia in cirrhosis: from pathogenesis to treatment.
    Ginés P; Berl T; Bernardi M; Bichet DG; Hamon G; Jiménez W; Liard JF; Martin PY; Schrier RW
    Hepatology; 1998 Sep; 28(3):851-64. PubMed ID: 9731583
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.
    Gerbes AL; Gülberg V; Ginès P; Decaux G; Gross P; Gandjini H; Djian J;
    Gastroenterology; 2003 Apr; 124(4):933-9. PubMed ID: 12671890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disturbed renal water excretion in cirrhosis.
    Schrier RW
    Gastroenterology; 1983 Apr; 84(4):870-2. PubMed ID: 6825997
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.
    Ginès P; Guevara M
    Hepatology; 2008 Sep; 48(3):1002-10. PubMed ID: 18671303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites.
    Arroyo V; Clària J; Saló J; Jiménez W
    Semin Liver Dis; 1994 Feb; 14(1):44-58. PubMed ID: 8016662
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aquaretic agents].
    Bosch-Marcé M; Clària J; Jiménez W
    Gastroenterol Hepatol; 1996 Nov; 19(9):472-7. PubMed ID: 8998673
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolvaptan and hyponatremia in a patient with cirrhosis.
    Boyer TD
    Hepatology; 2010 Feb; 51(2):699-702. PubMed ID: 20101750
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaptans and the treatment of water-retaining disorders.
    Quittnat F; Gross P
    Semin Nephrol; 2006 May; 26(3):234-43. PubMed ID: 16713496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolvaptan (Samsca) for hyponatremia.
    Med Lett Drugs Ther; 2009 Nov; 51(1326):95-6. PubMed ID: 20224525
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on the current management of hyponatremia.
    Lindner G; Schwarz C
    Minerva Med; 2012 Aug; 103(4):279-91. PubMed ID: 22805620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C; Pistrosch F; Herbrig K; Gross P
    Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia.
    Finley JJ; Konstam MA; Udelson JE
    Circulation; 2008 Jul; 118(4):410-21. PubMed ID: 18645067
    [No Abstract]   [Full Text] [Related]  

  • 13. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F; Blei AT; Blendis LM; Thuluvath PJ
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyponatremia treatment guidelines 2007: expert panel recommendations.
    Verbalis JG; Goldsmith SR; Greenberg A; Schrier RW; Sterns RH
    Am J Med; 2007 Nov; 120(11 Suppl 1):S1-21. PubMed ID: 17981159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aquaretic agents].
    Jiménez W
    Nefrologia; 2002; 22 Suppl 5():52-5. PubMed ID: 12107918
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyponatremia in cirrhosis with ascites].
    Bronzi G; Orlando D; De Feudis L; Delle Monache G; Scudieri M; Sergiacomo L; Bernardi M; Pesa O
    Minerva Med; 1990 Sep; 81(9):591-6. PubMed ID: 2234478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatremia in liver cirrhosis: pathophysiological principles of management.
    Castello L; Pirisi M; Sainaghi PP; Bartoli E
    Dig Liver Dis; 2005 Feb; 37(2):73-81. PubMed ID: 15733516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin antagonists in the treatment of water-retaining disorders.
    Kumar S; Berl T
    Semin Nephrol; 2008 May; 28(3):279-88. PubMed ID: 18519088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
    Chen S; Jalandhara N; Batlle D
    Nat Clin Pract Nephrol; 2007 Feb; 3(2):82-95. PubMed ID: 17251996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of ascites and hyponatremia in cirrhosis.
    Ginès P; Cárdenas A
    Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.